Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for Humoral Acute Rejection After Renal Transplantation
NCT01066689Phase 3Unknown
- Sponsor
- University Hospital Tours
- Start
- Oct 2008
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in graft rejection, sponsored by University Hospital Tours. Status: unknown.
02
Drugs
rituximab
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT01066689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066689.